UK Launch · The Ped Shop Exclusive

A new name in research peptides, landing in the UK

SerenQ Pharmaceuticals builds research peptides into sealed, pre-filled injection pens rather than lyophilised vials. No reconstitution, no bacteriostatic water, no guesswork with a syringe barrel. Dial the units you need, read them off the window, done.

SerenQ has appointed

The Ped Shop as its exclusive UK stockist

. Every pen sold here comes direct from the manufacturer, in sealed retail cartons, with a unique serial number and QR authenticity code on the label.

SerenQ Pharmaceuticals

Cagrilintide

Peptide Injection Pen System

Content

Cagrilintide 15mg

Dial graduation

10u = 500mcg

Per unit

Total units

Format

Pre-filled pen

Pen tips

32G 0.23 x 4mm

Expiry

12/2027

Authenticity

QR + serial

Composition & Dosing Guide

Cagrilintide 15mg · 3 ml pen · 300 units

Total volume

3 ml

Total liquid in the pen

Total contents

15 mg

Cagrilintide in the pen

Dosing scale

0.01 ml = 1 unit

Each unit on the pen dial equals 0.01 ml

Concentration

5.00 mg/ml

Cagrilintide per millilitre

Dosing examples

Units

Volume (ml)

Cagrilintide (mg)

| 2 units

| 0.02 ml

| 0.10 mg

| 4 units

| 0.04 ml

| 0.20 mg

| 6 units

| 0.06 ml

| 0.30 mg

| 8 units

| 0.08 ml

| 0.40 mg

| 10 units

| 0.10 ml

| 0.50 mg

| 12 units

| 0.12 ml

| 0.60 mg

| 14 units

| 0.14 ml

| 0.70 mg

| 16 units

| 0.16 ml

| 0.80 mg

| 18 units

| 0.18 ml

| 0.90 mg

| 20 units

| 0.20 ml

| 1.00 mg

| …

| 300 units

| 3.00 ml (full pen)

| 15.00 mg (total)

Key example

10 units = 0.10 ml

, the pen’s dial graduation, containing 0.50 mg Cagrilintide.

Figures are the pen’s stated contents divided across its 300 units. For research purposes only. Not for human consumption.

Third Party Testing

Results pending

Every SerenQ batch is sent for independent analysis before it goes on general sale. Purity and identity testing for this batch is currently with

Analiza

, and the certificate will be published on this page the moment it lands.

Laboratory

Analiza

Test

Purity & identity

Method

HPLC / MS

Status

Awaiting report

Check back here for the full certificate, or ask us and we will send it over as soon as it is released.

Serialised & QR Verified

Every SerenQ product carries a unique serial number and a QR code printed on the label. Scan it with any phone camera and you can independently confirm the pen is genuine SerenQ stock and check its batch details before you open the carton.

One code per pen. Each one can only be registered once, so a duplicate scan is an immediate red flag.

You can verify your SerenQ authenticity and view the latest HPLC at

About Cagrilintide

Cagrilintide is a long acting analogue of amylin, the hormone co-secreted with insulin by the same pancreatic beta cells. Native amylin has a half life of minutes and aggregates readily, both of which make it useless as a drug; cagrilintide is engineered around those problems, with a fatty acid chain that binds albumin and extends its life to something compatible with weekly administration.

Its mechanism is deliberately different from the GLP-1 class. Amylin signals satiety through the area postrema in the brainstem and slows gastric emptying, acting on the sense of fullness during and after a meal. GLP-1 agonists act on appetite and food reward through partly separate pathways. Because the two do not overlap completely, combining them produces more effect than either alone.

That combination is the reason cagrilintide exists commercially. Novo Nordisk has taken it into phase III as CagriSema, a fixed combination with semaglutide, and the trial results have shown weight loss exceeding semaglutide by itself. As a single agent, cagrilintide is meaningfully weaker than a GLP-1, which is important context for anyone considering it alone.

Where the evidence sits:

cagrilintide has completed phase II as a monotherapy and is in phase III in combination with semaglutide, so there is real human trial data behind it. It holds no marketing authorisation anywhere yet, and almost all of the strong results come from the combination rather than from cagrilintide on its own.

The pen format

Cagrilintide is a weekly compound and the trial doses climb through a titration schedule rather than starting at the top. A 500mcg dial step makes that titration straightforward instead of an exercise in eyeballing a syringe.

15.00mg of Cagrilintide

per pen, in solution and ready to use

1 unit = 50mcg.

10 units on the dial gives 500mcg

300 units in total

, which works out at 30 full 500mcg draws per pen

– Dial and dose window let you set the exact amount and read it back before dispensing

– 4 screw on pen tips supplied, individually sealed,

32G 0.23 x 4mm

– Protective cap, clip and a rigid retail carton for storage and transport

– Batch number, expiry and serial printed directly on the pen barrel, not just the box

Handling and storage

– Store refrigerated at 2 to 8°C. Do not freeze

– Keep in the outer carton, away from direct light

– Short periods at room temperature during transit are expected and normal

– Use a fresh sealed tip for each dispense and dispose of tips in a sharps container

– Expiry 12/2027 on sealed, correctly stored stock

– Keep out of reach of children and animals

What is in the box

– 1 × SerenQ Cagrilintide 15mg pre-filled injection pen

– 4 × sealed pen tips, 32G 0.23 x 4mm

– Serialised, QR coded retail carton

Choosing between Cagrilintide, Tirzepatide and Retatrutide

The honest framing is that cagrilintide is not really a competitor to the other two, it is a complement.

Tirzepatide

is a dual GIP and GLP-1 agonist and

adds glucagon receptor activity on top; both produce substantially more weight loss as single agents than cagrilintide does. If you are choosing one compound and the goal is fat loss, one of those two is the rational pick.

Where cagrilintide earns its place is alongside a GLP-1 rather than instead of one, which is